Correction to: Left atrial shunting devices: why, what, how, and… when?
Heart Failure Reviews · 11.06.2026 · 31 (1)
DOI: 10.1007/s10741-026-10642-2 ↗Kurz gefasst
Korrektur in der Zeitschrift Heart Failure Reviews, online erschienen am 11.06.2026. Verfasst von Leila Anna De Lorenzo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Università Vita E Salute San Raffaele, Milan, Italy. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Università Vita E Salute San Raffaele, Milan, Italy.
- Department of Cardiology, San Luca Hospital, IRCCS Istituto Auxologico Italiano, Milan, Italy.
- Department of Management, Information and Production Engineering, University of Bergamo, Edificio C, Via Pasubio, 24044, Dalmine, Bergamo, Italy.
- Department of Cardiology, San Luca Hospital, IRCCS Istituto Auxologico Italiano, Milan, Italy. sergio.caravita@unibg.it.
- Department of Management, Information and Production Engineering, University of Bergamo, Edificio C, Via Pasubio, 24044, Dalmine, Bergamo, Italy. sergio.caravita@unibg.it.
- Dyspnea and Pulmonary Hypertension Center, Ospedale San Luca, Piazzale Brescia 20, 20149, Milano, Italy. sergio.caravita@unibg.it.
Zitieren
APA
De Lorenzo, L. A., Baratto, C., Sala, D., Perego, G. B., & Caravita, S. (2026). Correction to: Left atrial shunting devices: why, what, how, and… when?. Heart Failure Reviews, 31(1). https://doi.org/10.1007/s10741-026-10642-2
Vancouver
De Lorenzo LA, Baratto C, Sala D, Perego GB, Caravita S. Correction to: Left atrial shunting devices: why, what, how, and… when?. Heart Failure Reviews. 2026;31(1). doi:10.1007/s10741-026-10642-2
BibTeX
@article{DeLorenzo2026,
author = {De Lorenzo, Leila Anna and Baratto, Claudia and Sala, Davide and Perego, Giovanni Battista and Caravita, Sergio},
title = {Correction to: Left atrial shunting devices: why, what, how, and… when?},
journal = {Heart Failure Reviews},
year = {2026},
volume = {31},
number = {1},
doi = {10.1007/s10741-026-10642-2}
}
EUVIMED